On Oct. 16, 2020, BD (Becton, Dickinson) announced the CE mark and European availability of a product for assessing immune function in COVID-19 patients.

The BD Multitest 6-Color TBNK Reagent with BD Trucount’ Tubes has been CE marked with expanded clinical application for the identification and enumeration of T-cell subtypes in COVID-19 patients, an innovation in helping clinicians better understand patient immune response to COVID-19 disease.